Health

My Herbal Medicines Are Well Accepted Across The Globe, Prof Amodu Reveals

Published

4 months ago

May 31, 2025

By David Maxwell

One of Nigeria’s leading voices in the support and propagation of herbal medicine, Professor Benjamin Amodu has revealed that his herbal medicines are widely accepted across the globe.

He made this revelation while speaking to our reporter at his laboratory in Abuja.

Amodu, known for his herbal cure for serveral communicable and non-communicable diseases like malaria, asthma, diabetes, enlarged heart, various cancers, chronic kidney disease even into the end stage, has boldly revealed that his herbal products enjoy a huge acceptance across the globe.

“Our medications are well accepted, both at home here in Nigeria and abroad too.

“This is because we’ve been sending our medicines not only to countries within the African continent, but also countries in Asia, the Middle East, Europe, America and even Oceania.

“We usually send our herbal medicines to Ghana, Cameroon, Egypt, South Africa and many other African countries, and even to Saudi Arabia, Iraq, the United Kingdom, USA, France, Australia, the Netherlands, Germany, Ireland, Canada and virtually everywhere around the world without any issues.

“We have been sending them to these places via DHL and we haven’t had any issues whatsoever.”
Amodu also spoke of the wide acceptance his his herbal medicines have been enjoying at home here in Nigeria.

He said, “even though we may not have had the support anymore expects from the government, but the Nigerian people are not waiting for the government to tell them to either accept our medications or not.

“Since many patients we have treated with our products and get cured of the ailments keep talking about and announcing for others to know, we haven’t had a short supply of patients who either come to us themselves or through family members and other caregivers.

“So if the USA, UK, Canada and all these other countries can accept our treatment, plus those at home here in Nigeria, then I can confidently say that my products are well recognized and accepted across the world.”

Having spent about four decades researching into Traditional, Complimentary and Alternative Medicine, TCAM, with scores of papers published in reputable health journals and peer reviewed, Amodu, a professor of phytomedicine from the Triune Biblical University, USA, is no doubt a leading advocate for alternative medicine.

Share on Facebook

Health

Experts call for pharma sector harmonisation

Published

2 months ago

August 14, 2025

The Gleamer

Health sector experts have called for the harmonisation of pharmaceutical activities in Nigeria to eliminate duplication, enhance efficiency, and improve access to quality medicines and health products.

The call was made on Wednesday in Abuja during a high-level stakeholders’ engagement focused on aligning efforts under the Improving Access to Medicines through Policy and Technical Support (IMPACT) project.

Dr Tayo Hamzat, Supply Chain Management Officer at the World Health Organisation (WHO), said the engagement was timely, considering the number of ongoing but uncoordinated interventions in the sector.

“Harmonisation will lead to faster access to health products, lower costs, improved efficiency, and better regulatory oversight.

“It requires collaboration and a focus on strengthening national systems.”

He described Nigeria’s pharmaceutical system as “robust and huge” but hindered by weak coordination and fragmented management structures.

Dr Francis Ohanyido, Director-General of the West Africa Institute of Public Health, said such collaboration was “common sense” given limited development financing and the need to optimise resources.

“Market shaping is a critical tool.
“Harmonisation can help us identify clear gaps we need to fill, especially in preparation for the African Continental Free Trade Area (AfCFTA),” he said.

Dr Anthony Ayeke, Programme Manager for Health and Nutrition at the EU Delegation to Nigeria and ECOWAS, reaffirmed the EU’s commitment to supporting a resilient, locally driven pharmaceutical sector.

“Harmonisation can accelerate local production, reduce import dependency, and improve healthcare system resilience,” he noted.

He also recommended regulatory streamlining, value chain capacity building, innovation, and public-private partnerships.

Dr Abdu Mukhtar, National Coordinator of the Pharmaceutical Value Chain Transformation Committee (PVAC), commended ongoing efforts under the IMPACT project.

Represented by Dr Muhammad Balarabe, Technical Associate at PVAC, he emphasised the committee’s focus on catalysing local production and attracting sustainable investment.

“Let’s use this platform to strengthen partnerships and align interventions with the vision of affordable, high-quality healthcare for all Nigerians,” he said.

Dr Obi Adigwe, Director-General of the National Institute for Pharmaceutical Research and Development (NIPRD), said fragmented interventions and redundant regulations had long stunted growth in the sector.

Represented by Prof. Philip Builders, Professor of Pharmaceutics at NIPRD he said: “Equitable access to quality medicine is the foundation of universal healthcare.

“The lack of access is not just a health issue; it’s about equity, national security, and economic survival.

“Harmonisation isn’t just about avoiding duplication; it’s about aligning policy, investment, and technical frameworks to achieve measurable results.”

He urged stakeholders to develop practical short, medium, and long-term strategies to make Nigeria’s pharmaceutical sector self-reliant, globally competitive, and able to meet national healthcare demands.

The meeting brought together key government agencies, development partners, and private sector actors, each reaffirming a shared commitment to a unified, efficient pharmaceutical ecosystem in Nigeria.

NAN

Share on Facebook